A team of researchers at the University of Louisville say they have developed a technology that could prevent the COVID-19 virus from infecting human cells by blocking its ability to replicate itself inside the body.
The researchers’ findings were reported Wednesday by the University of Louisville’s UofL News’ Baylee Pulliam, who covers research and innovation at the university. The “breakthrough technology,” writes Pulliam, “is believed to block the novel coronavirus SARS-CoV-2 from infecting human cells.”
“The technology is based on a piece of synthetic DNA – an ‘aptamer’ – which targets and binds with a human protein called nucleolin,” Pulliam explains. “Early tests show that this aptamer may stop viruses, including novel coronavirus, from ‘hijacking’ nucleolin to replicate inside the body.”
Because of the promising results of their early testing, the university is seeking to “fast-track development, including application to the Food and Drug Administration for approval to start treating